International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 4 , Pages 1083-1091 , 15 July 2009

Postoperative External Beam Radiotherapy for Differentiated Thyroid Cancer: Outcomes and Morbidity With Conformal Treatment

  • David L. Schwartz, M.D.

      Affiliations

    • Department of Radiation Oncology, UT M.D. Anderson Cancer Center, Houston, TX
    • Department of Experimental Diagnostic Imaging, UT M.D. Anderson Cancer Center, Houston, TX
    • Corresponding Author InformationReprint requests to: David L. Schwartz, M.D., Department of Radiation Oncology, Unit 97, UT M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. Tel: (713) 563-2381; Fax: (713) 563-2331
    • ,
  • Mark J. Lobo, M.D.

      Affiliations

    • Department of Radiation Oncology, UT M.D. Anderson Cancer Center, Houston, TX
    • ,
  • K. Kian Ang, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, UT M.D. Anderson Cancer Center, Houston, TX
    • ,
  • William H. Morrison, M.D.

      Affiliations

    • Department of Radiation Oncology, UT M.D. Anderson Cancer Center, Houston, TX
    • ,
  • David I. Rosenthal, M.D.

      Affiliations

    • Department of Radiation Oncology, UT M.D. Anderson Cancer Center, Houston, TX
    • ,
  • Anesa Ahamad, M.D.

      Affiliations

    • Department of Radiation Oncology, UT M.D. Anderson Cancer Center, Houston, TX
    • ,
  • Douglas B. Evans, M.D.

      Affiliations

    • Department of Surgical Oncology, UT M.D. Anderson Cancer Center, Houston, TX
    • ,
  • Gary Clayman, M.D., D.D.S.

      Affiliations

    • Department of Head and Neck Surgery, UT M.D. Anderson Cancer Center, Houston, TX
    • ,
  • Steven I. Sherman, M.D.

      Affiliations

    • Department of Endocrine Neoplasia and Hormonal Disorders, UT M.D. Anderson Cancer Center, Houston, TX
    • ,
  • Adam S. Garden, M.D.

      Affiliations

    • Department of Radiation Oncology, UT M.D. Anderson Cancer Center, Houston, TX

Received 8 July 2008 ,Revised 10 September 2008 ,Accepted 23 September 2008.

References 

  1. Benker G, Olbricht T, Reinwein D, et al. Survival rates in patients with differentiated thyroid carcinoma. Influence of postoperative external radiotherapy. Cancer. 1990;65:1517–1520
  2. Chung CT, Sagerman RH, Ryoo MC, et al. External irradiation for malignant thyroid tumors. Radiology. 1980;136:753–756
  3. Farahati J, Reiners C, Stuschke M, et al. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer. 1996;77:172–180
  4. Harmer CL. External beam radiotherapy for thyroid cancer. Ann Radiol (Paris). 1977;20:791–800
  5. Phlips P, Hanzen C, Andry G, et al. Postoperative irradiation for thyroid cancer. Eur J Surg Oncol. 1993;19:399–404
  6. Sheline GE, Galante M, Lindsay S. Radiation therapy in the control of persistent thyroid cancer. Am J Roentgenol Radium Ther Nucl Med. 1966;97:923–930
  7. Simpson WJ, McKinney SE, Carruthers JS, et al. Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients. Am J Med. 1987;83:479–488
  8. Tsang RW, Brierley JD, Simpson WJ, et al. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer. 1998;82:375–388
  9. Wu XL, Hu YH, Li QH, et al. Value of postoperative radiotherapy for thyroid cancer. Head Neck Surg. 1987;10:107–112
  10. O'Connell ME, A'Hern RP, Harmer CL. Results of external beam radiotherapy in differentiated thyroid carcinoma: A retrospective study from the Royal Marsden Hospital. Eur J Cancer. 1994;30A:733–739
  11. Esik O, Nemeth G, Eller J. Prophylactic external irradiation in differentiated thyroid cancer: A retrospective study over a 30-year observation period. Oncology. 1994;51:372–379
  12. Ford D, Giridharan S, McConkey C, et al. External beam radiotherapy in the management of differentiated thyroid cancer. Clin Oncol (R Coll Radiol). 2003;15:337–341
  13. Meadows KM, Amdur RJ, Morris CG, et al. External beam radiotherapy for differentiated thyroid cancer. Am J Otolaryngol. 2006;27:24–28
  14. Kim TH, Yang DS, Jung KY, et al. Value of external irradiation for locally advanced papillary thyroid cancer. Int J Radiat Oncol Biol Phys. 2003;55:1006–1012
  15. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: A 10 year follow-up report of the impact of therapy in 576 patients. Am J Med. 1981;70:511–518
  16. Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992;75:714–720
  17. Jensen MH, Davis RK, Derrick L. Thyroid cancer: A computer-assisted review of 5287 cases. Otolaryngol Head Neck Surg. 1990;102:51–65
  18. Chow SM, Yau S, Kwan CK, et al. Local and regional control in patients with papillary thyroid carcinoma: Specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition. Endocr Relat Cancer. 2006;13:1159–1172
  19. Lee N, Tuttle M. The role of external beam radiotherapy in the treatment of papillary thyroid cancer. Endocr Relat Cancer. 2006;13:971–977
  20. Simpson WJ, Panzarella T, Carruthers JS, et al. Papillary and follicular thyroid cancer: Impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys. 1988;14:1063–1075
  21. Tubiana M, Haddad E, Schlumberger M, et al. External radiotherapy in thyroid cancers. Cancer. 1985;55:2062–2071
  22. Coburn MC, Wanebo HJ. Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg. 1992;164:671–676
  23. Vassilopoulou-Sellin R, Schultz PN, Haynie TP. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Cancer. 1996;78:493–501
  24. Rosenbluth BD, Serrano V, Happersett L, et al. Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer. Int J Radiat Oncol Biol Phys. 2005;63:1419–1426
  25. Urbano TG, Clark CH, Hansen VN, et al. Intensity modulated radiotherapy (IMRT) in locally advanced thyroid cancer: Acute toxicity results of a phase I study. Radiother Oncol. 2007;85:58–63
  26. Finkelstein SE, Grigsby PW, Siegel BA, et al. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer. Ann Surg Oncol. 2008;15:286–292

 Supported in part by P01 CA06294, awarded by the National Cancer Institute.

 Presented in part at the Seventh International Conference on Head and Neck Cancer, San Francisco, CA, July 2008, and the 50th Scientific Meeting of the American Society of Therapeutic Radiology and Oncology, Boston, MA, September 20–24, 2008.

 Conflict of interest: none.

PII: S0360-3016(08)03497-4

doi: 10.1016/j.ijrobp.2008.09.023

International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 4 , Pages 1083-1091 , 15 July 2009

Article Tools

* Image Usage & Resolution